期刊文献+

CD147在甲状旁腺癌中的表达及其临床意义 被引量:1

Expression and clinical significance of CD147 in parathyroid carcinoma
原文传递
导出
摘要 目的探讨CD147在甲状旁腺癌中的表达及其临床意义。方法收集2012--2015年14例甲状旁腺癌及33例甲状旁腺腺瘤病例,运用免疫组织化学EnVision法检测CD147在甲状旁腺癌和甲状旁腺腺瘤中的表达情况。结果CD147阳性显色为棕黄色,以胞膜着色为主,出现少量胞质着色。14例甲状旁腺癌,其中11例CD147阳性3+,3例CD147阳性2+;33例甲状旁腺腺瘤病例,其中8例CD147阳性2+,15例阳性1+,10例阴性。CD147在甲状旁腺癌组织中高表达,与在甲状旁腺腺瘤中的表达情况相比,差异具有统计学意义(P〈0.05)。结论免疫组织化学染色CD147在甲状旁腺癌组织中高表达可辅助诊断甲状旁腺癌。 Objective To study the expression and clinical significance of CD147 in the patients of parathyroid carcinoma. Methods Fourteen cases of parathyroid carcinoma encountered during the period from 2012 to 2015 were enrolled. Thirty three cases of parathyroid adenoma encountered during the same period were enrolled. The expression of CD147 in parathyroid carcinoma and parathyroid adenoma was studied by means of immunohistochemistry ( EnVision method). Results CD147 positive color was brown and yellow, and positive position was located mainly in the cytomembrane, and a small amount of cytoplasm was appeared. Among 14 cases of parathyroid carcinoma, 11 cases of CD147 positive score was 3 + , 3 cases of CD147 positive score was 2 + ; Among 33 cases of parathyroid adenoma , 8 cases of CD147 positive score was 2 + , 15 cases of it was 1 + , 10 cases of it was negative. CD147 was highly expressed in parathyroid carcinoma tissues, and the expression of CD147 was significantly different from the expression of parathyroid adenoma(P 〈0. 05 ). Conclusion CD147 immunohistochemical staining can help to diagnose parathyroid carcinoma.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2016年第6期372-374,共3页 Chinese Journal of Pathology
关键词 甲状旁腺肿瘤 免疫组织化学 诊断 鉴别 Parathyroid neoplasms Immunohistochemistry Diagnosis,differential
  • 相关文献

参考文献15

  • 1DeLellis RA, Lloyd RV, Heitz PU, et al. World Health Organization classification of tumors. Pathology and genetics of tumors of endocrine organs [ M ]. Lyon : IARC Press,2002 : 139.
  • 2Nabeshima K, Iwasaki H, Koga K, et al. Emmprin ( basigin/ CD147 ) : matrix metalloproteinase modulator and muhifunctional cell recognition molecule that plays a critical role in cancer progression[J]. Pathol Int,2006,56 (7) : 359-367.
  • 3刘雷,郭磊,王志威,计骏,张佳年,燕敏,刘炳亚,朱正纲,于颖彦.新型标志物HAb18G/CD147在大样本胃癌组织中的表达研究[J].诊断学理论与实践,2012,11(1):42-46. 被引量:3
  • 4徐小艳,郅程,李玉梅,齐文娟,梅娟娟,严智敏,申洪.肝细胞膜表面相关抗原与非小细胞肺癌临床病理特征和预后的关系[J].中华病理学杂志,2012,41(3):151-155. 被引量:8
  • 5朱少君,米力,李艳红,张阳,巩丽,韩秀娟,姚丽,兰淼,张伟.HAb18G/CD147在食管鳞状细胞癌中的表达及其临床意义[J].细胞与分子免疫学杂志,2011,27(7):784-786. 被引量:2
  • 6Liu F,Cui L,Zhang Y,et al. Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma [J]. Breast Cancer Res Treat, 2010, 124 ( 3 ) : 677-688. DOI: 10. 1007/s10549-010-0790-6.
  • 7Yurchenko V, Constant S, Bukrinsky M. Dealing with the family: CD147 interactions with cyclophilins [J].Immunology, 2006,117 (3) :301-309.
  • 8Guo H, Li R, Zucker S, et al. EMMPRIN (CD147) , an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface [ J ]. Cancer Res, 2000,60 (4) : 888-891.
  • 9Li Y, Xu J, Chen L, et al. HAbl8G (CD147), a cancer- associated biomarker and its role in cancer detection [J]. Histopathology,2009,54 ( 6 ) : 677-687. DOI : 10. 1111/j. 1365- 2559. 2009. 03280. x.
  • 10Xu T,Zhou M, Peng L, et al. Upregulation of CD147 promotes cell invasion, epithelial-tormesenchymal transition and activates MAPK/ERK signaling pathway in colorectal cancer[J]. Int J Clin Exp Pathol,2014,7( 11 ) :7432-7441.

二级参考文献50

  • 1申洪.免疫组织化学染色定量方法研究(Ⅲ)[J].中国组织化学与细胞化学杂志,1995,4(1):89-92. 被引量:400
  • 2蒋建利,姚西英,周筠,黄勇,张阳,陈志南.HAb18G/CD147刺激人肝癌细胞分泌基质金属蛋白酶的机制探讨[J].肿瘤,2004,24(6):534-537. 被引量:9
  • 3陈翔,林静,林伟,粟娟,陈明亮,施为,谢红付,陈服文.CD147 siRNA对恶性黑素瘤细胞株A375增殖及CD147表达的影响[J].中华皮肤科杂志,2006,39(4):204-206. 被引量:6
  • 4Nabeshima K, Iwasaki H, Koga K, et al. Emmprin (basi- gin/CD147): matrix metalloproteinase modulator and mul- tifunctional cell recognition molecule that plays a critical role in cancer progression[J]. Pathol Int,2006,56(7):359- 367.
  • 5Xu J, Xu HY, Chen ZN, et al. HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma[J]. Mol Cancer Res,2007,5(6):605-61g.
  • 6Sun J, Hemler ME. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metallo- proteinase inducer interactions[J]. Cancer Res,2001,61(5): 2276-2281.
  • 7Liu F, Cui L, Zhang Y, et al. Expression of HAb18G isassociated with tumor progression and prognosis of breast carcinoma[J]. Breast Cancer Res Treat,2010,124(3):677- 688.
  • 8Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009 [J]. CA Cancer J Clin, 2009,59(4):225-249.
  • 9Sobin LH, Wittekind C. International Union Against Can- cer (UICC) TNM classification of malignant tumours [M]. 6th edition. New York: Wiley,2002:70-72.
  • 10Ichikura T, Tomimatsu S, Uefuji K, et al. Evaluation of the new American Joint Committee on Cancer/Interna- tional Union against cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification[J]. Cancer,1999,86(4):553-558.

共引文献24

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部